BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 14, 2005
View Archived Issues
Caveolin-1 binding domain of HIV-1 gp41 as an epitope for a vaccine candidate/News in Context
Read More
sanofi-aventis reaffirms commitment to VEGF Trap alliance with Regeneron
Read More
Remune completes phase II studies in Italy, Spain
Read More
Safinamide shows promise in restless legs syndrome pilot study
Read More
Sunesis extends Cathepsin S inhibitor collaboration with Johnson & Johnson
Read More
TaiGen enters strategic alliance with P&G for antibiotic compound
Read More
Campral available in U.S.
Read More
BioAxone cleared to commence U.S. clinical development of Cethrin
Read More
Manufacturing milestone towards IND filing for PSA-PAH1
Read More
Enrollment begins in phase III Alzheimer's study of Flurizan
Read More
SPA for Avanir's phase III study of Neurodex
Read More
Positive phase IIa data for subset of patients treated with Miraxion
Read More
Positive data for oral Rambazole in psoriasis
Read More
Phase IIa data show utility of oral azoline in superficial fungal infections
Read More
FAS-20013 to enter clinical trials in TB and multidrug-resistant TB this year
Read More
Phase III study of long-acting injectable paliperidone palmitate in schizophrenia
Read More
KRX-101 phase II/III program recommended to continue to phase III
Read More
PEGylated integrin alpha4beta1 inhibitor with improved pharmacokinetic and pharmacodynamic profiles
Read More
Dextofisopam reported effective and well tolerated in IBS
Read More
PET scans provide new data on the effects of EMD-281014 in brain
Read More
Two clinical studies support the use of recombinant human albumin as an alternative to HSA
Read More
Phase III data on the effects of peginterferon alfa-2b plus ribavirin in HIV-HCV coinfection
Read More
MRS-2365: a novel, potent and selective P2Y1 receptor agonist
Read More
Nicotinic acetylcholine alpha7 receptor agonist with potential for the treatment of schizophrenia
Read More
PDE4 inhibitors described by Merck Frosst
Read More
sanofi-aventis patent claims CCR2B receptor antagonists
Read More
A series of quinolones for the treatment of CNS disorders
Read More
Scientists at 3-Dimensional Pharmaceuticals present novel protein tyrosine kinase inhibitors
Read More
Pfizer researchers report discovery of compounds with utility in diagnosis of CNS disorders
Read More
A series of antibacterial compounds described in patent literature
Read More
AstraZeneca prepares and tests vanilloid receptor antagonists
Read More